Study 2 of 2 for search of: "Siderosis"
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients
This study has been completed.
Sponsored by: Imperial College London
Information provided by: Imperial College London
ClinicalTrials.gov Identifier: NCT00520559
  Purpose

The purpose of this study is to provide accurate prognostic data linking cardiac complications to myocardial T2* values (A measure of iron levels in the heart using MRI)in patients predisposed to heart iron overload.


Condition
Thalassemia

Genetics Home Reference related topics: beta thalassemia
MedlinePlus related topics: Anemia Thalassemia
U.S. FDA Resources
Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Retrospective Study
Official Title: Incidence of Cardiac Complications in Patients With Cardiac Siderosis During 1 Year Follow−up and the Normal T2* Ranges in LVF, MI and Normal Population.

Further study details as provided by Imperial College London:

Enrollment: 665
Study Start Date: January 2007
Study Completion Date: August 2007
  Show Detailed Description

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Thalassaemia Major
  • Patient must have had a cardiac MRI scan between 1999 and 2006

Exclusion Criteria:

  • Other structural heart disease such as valvular abnormalities, MI, congenital heart disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00520559

Sponsors and Collaborators
Imperial College London
Investigators
Principal Investigator: Dudley Pennell, MA, MD Imperial College London
  More Information

Study ID Numbers: 07/MRE04/32
Study First Received: August 23, 2007
Last Updated: August 23, 2007
ClinicalTrials.gov Identifier: NCT00520559  
Health Authority: United Kingdom: National Health Service;   United Kingdom: Research Ethics Committee

Study placed in the following topic categories:
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hematologic Diseases
Hemoglobinopathies
Anemia
Anemia, Hemolytic
Siderosis
Hemoglobinopathy
Thalassemia

ClinicalTrials.gov processed this record on January 16, 2009